NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Medical Distribution · USD

McKesson Corporation (MCK) Stock Analysis

McKesson Corporation (MCK) is a Medical Distribution stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

MCK

$1,015.50

−$14.62 (−1.42%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MCK with… →

MCK Key Statistics

As of Oct 21, 2026
Trading
Open
$1,020.93
Previous Close
$1,030.12
Day's Range
1,005.42–1,030.00
52-Week Range
723.68–1,030.27
Volume
734.09K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.30
Valuation
Market Cap
$118.40B
P/E Ratio
27.22
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
20.08
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.94
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.29
EPS (ttm)Profit attributable to each share over the last twelve months.
37.31
Financials (FY)
Revenue (FY)
$403.43B+12.36%
Net Income (FY)
$4.76B+44.52%
Profit marginThe share of revenue left as profit after all costs and taxes.
1.12%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
116.59M
1-Year Return
+29.49%
Dividend and dates
Dividend
$3.76+0.37%
Ex-Dividend Date
September 1, 2026
Earnings Date
November 4, 2026
Avg Volume
896.99K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, MCK closed at $1,015.50, +29.49% over 1 year.

McKesson Corporation (MCK) has a market capitalization of $118.40B.

In fiscal 2025, MCK reported revenue of $403.43B.

MCK Stock Return by Calendar Year

McKesson Corporation (MCK) 10-year return: what $10,000 became

1 year
$10,000 $12,949
+29.49%
5 years
$10,000 $50,293
+402.93%
10 years
$10,000 $68,044
+580.44%

If you had invested $10,000 in McKesson Corporation (MCK) 10 years ago, at the close on October 21, 2016, it would have been worth $68,044 at the close on October 21, 2026: +580.44% in total, +21.14% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+24.17%
2025+44.54%
2024+23.67%
2023+24.13%
2022+51.82%
2021+44.23%
2020+27.06%
2019+26.72%
2018−28.40%
2017+11.95%
2016 (partial year)−27.84%

As of October 21, 2026.

MCK Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$403.43B$4.76B1.2%
2024$359.05B$3.30B0.9%
2023$308.95B$3.00B1.0%
2022$276.71B$3.56B1.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$403.43B$14.55B$6.45B$4.76B1.2%
2024$359.05B$13.32B$4.82B$3.30B0.9%
2023$308.95B$12.83B$4.17B$3.00B1.0%
2022$276.71B$12.36B$4.58B$3.56B1.3%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

MCK Dividend History

$3.06+15.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$2.583—
2025$3.064+15.0%
2024$2.664+14.7%
2023$2.324+14.9%
YearDividends per sharePaymentsChange
2026 (partial year)$2.583—
2025$3.064+15.0%
2024$2.664+14.7%
2023$2.324+14.9%
2022$2.024+13.5%
2021$1.784+7.2%
2020$1.664+3.7%
2019$1.604+9.6%
2018$1.464+17.7%
2017$1.244+342.9%
2016$0.281—

Most recent payment: $0.86 per share, ex-dividend September 1, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

MCK Valuation vs Medical Distribution Median

Median of 11 stocks
MetricMCKMedical Distribution medianvs median
P/E27.2226.244% above
P/S ratio0.290.3825% below
Profit margin1.12%−4.73%5.8 pts above

Medians across 11 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values McKesson Corporation (MCK) at $118.40B. It is classified in the Medical Distribution industry, within the Healthcare sector. The company reports 41,600 employees.

MCK last closed at $1,015.50 on October 21, 2026. That is −$14.62 (−1.42%) against the previous close. Over the past 52 weeks the price has ranged from $723.68 to $1,030.27. The latest close sits 40.32% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $403.43B. Against the prior fiscal year total of $359.05B, that is a change of +12.36%. Net income for the same year was $4.76B. That is +44.52% against the prior fiscal year. The reported profit margin is 1.12%. That is 5.8 percentage points above the Medical Distribution median of −4.73%. Trailing earnings per share are 37.31.

Across the 4 fiscal years on file, revenue moves from $276.71B in 2022 to $403.43B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 27.22. That is 3.71% above the Medical Distribution median of 26.24. The forward P/E on file is 20.08. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.94. Measured against sales, the shares trade at 0.29 times revenue. On price-to-sales that is 24.81% below the Medical Distribution median of 0.38. The medians here are taken across 11 Medical Distribution companies that report the metric.

Over the trailing twelve months the total return is +29.49%. Measured over 10 years, that is +21.14% a year compounded. Beta against the wider market is reported at 0.3. Daily returns over the trailing 10 years annualize to a volatility of 29.13%.

Growth & Income

Shareholders receive a dividend, yielding 0.37% on the latest price. That is 0.3 percentage points below the Medical Distribution median yield of 0.7%. The indicated annual rate is $3.76 a share. The ex-dividend date on file is September 1, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $2.58 a share. The year before, 2025, totalled $3.06 a share.

So far in 2026 the total return is +24.17%. Across the complete calendar years on file, 2022 returned +51.82% and 2018 returned −28.40%. Of the 9 complete calendar years on file, 8 finished higher.

Peer Comparison

McKesson Corporation (MCK) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
McKesson Corporation MCK $118.40B 27.2
Cencora, Inc. COR $64.96B 25.3
Cardinal Health, Inc. CAH $58.83B 35.1
Henry Schein, Inc. HSIC $9.47B 24.8

The Medical Distribution industry average P/E ratio is 26.2x. McKesson Corporation trades at a P/E of 27.2.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Distribution Stocks

COR

Cencora, Inc.

$64.96B

 CAH

Cardinal Health, Inc.

$58.83B

 HSIC

Henry Schein, Inc.

$9.47B

 AHG

Akso Health Group

$1.09B

 FOCL

EDAP TMS S.A.

$206.34M

 COSM

Cosmos Health Inc.

$28.25M
View all Medical Distribution stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Visit website →